New GDP-Compliant Facility Expanded and Relocated to Serve its Pharma Clients in Switzerland
RESEARCH TRIANGLE PARK, North Carolina, Aug. 11, 2016 /PRNewswire/ -- Marken announced the opening of their latest GDP-compliant operations center in Zurich, Switzerland, responding to increased demand from local pharmaceutical companies with growing clinical development programs.
The new location is within close vicinity to the Zürich Airport (Kloten) freight terminal and is strategically located near major Swiss highways. The facility, which operates 24/7/365, includes office and warehouse space with refrigerators and freezers available for temperature controlled packaging, full security and is connected to Marken's global 'Maestro' operating system. The operation will be fully staffed, capable of collecting and shipping clinical drug product from the Zurich gateway to anywhere in the world. The facility also conforms to the Swiss Minergie (green) standard, a registered quality label for new and refurbished low-energy-consumption buildings.
Wes Wheeler, Chief Executive Officer for Marken, commented, "Marken has built a global logistics network specifically designed to meet the needs of the global pharmaceutical industry. Our newest site in Zurich replaces our smaller office with expanded capabilities so that we can be ready for the increased clinical logistics demands from our clients. We have also set the standard for GDP compliance – especially in Europe - and will certify the operations according to our own 'Gold Book' standard."
Wheeler concluded: "We are the only 100%-dedicated, patient centric supply chain organization in the life sciences industry. We will continue to expand our global footprint to meet the increasingly demanding requirements of our clients."
The new office location is located and can be reached as follows:
Marken Switzerland AG
Phone: +41 44 319 80 50
Fax: +41 44 319 80 51
Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant depot network and logistic hubs in 43 locations worldwide. Marken's 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry.